<p>/PRNewswire/ -- Inari Medical，現在是 Stryker（紐約證券交易所代碼：SYK）的一部分，Stryker 是全球醫療技術的領導者，宣佈推出其 Artix 血栓切除系統。Artix 專為外周動脈系統的獨特需求而設計，是一種結合了吸引和機械血栓切除的解決方案，提供了程序控制和靈活性，旨在為動脈血栓切除設定新的標準。</p>
<p>繼續閲讀</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/></p>
<p>Artix™血栓切除系統</p>
<p>腿部的動脈血栓是一種危及生命和肢體的緊急情況，需要立即治療。然而，現有的動脈血栓栓塞治療可能導致：</p>
<ul>
<li>無效的血栓取出，導致額外的手術（開放手術或截肢 1,2）</li>
<li>大量失血 1</li>
<li>不良事件，如動脈栓塞和血管損傷 2,3</li>
<li>溶栓藥物使用率高，可能導致併發症 1,2</li>
</ul>
<p>Artix 系統建立在 Inari 靜脈血栓切除設備成功的基礎上，是其首次進入動脈領域。Inari 提供了一種全面的工具包方法來進行動脈血栓切除，採用創新的導線系統，使醫生能夠靈活地吸引和/或機械性提取血栓。</p>
<p>康涅狄格州諾沃克醫院血管外科主任 Jonathan Bowman 博士於 2024 年 10 月 19 日進行了首例 Artix 商業案例。Bowman 博士表示：“Artix 血栓切除系統標誌着外周動脈血栓栓塞治療的重大進展。使用 Artix，我終於有了一個有效解決各種血栓的方案，同時能夠在整個過程中保持血管通路和控制。我預計 Artix 將在我的許多動脈病例中取代開放手術修復。”</p>
<p>Artix 系統的主要獨特特點包括：</p>
<ul>
<li><strong>雙重機械血栓切除和吸引工具包</strong>，旨在通過簡化的程序在一次會話中去除急性到慢性血栓 4</li>
<li><strong>具備吸引功能的 8 Fr 低剖面、可追蹤、抗彎曲的鞘管，長度為 65cm 和 90cm</strong>，通過支持更復雜和遠端的干預擴展治療選項</li>
<li><strong>創新的導線機械元件</strong>，旨在有效收集和提取急性至慢性血栓 4</li>
<li><strong>覆蓋的鎳鈦合金網漏斗</strong>，在手術過程中提供臨時流量限制，以最小化動脈血栓遷移的風險 5</li>
</ul>
<p>“確實需要解決慢性血栓並降低血栓遷移的風險。Artix 將提升有效動脈血栓切除的標準，” Inari Medical 首席醫療官 Tom Tu 博士表示。“我們很高興將 Inari 在血栓切除方面的核心能力帶入動脈領域，以改善治療結果。”</p>
<p><strong>欲瞭解更多信息，請訪問 https://www.inarimedical.com/artix-system</strong></p>
<p><strong>關於 Stryker</strong> Stryker 是全球醫療技術的領導者，與我們的客户一起，我們致力於改善醫療保健。我們提供創新的產品和服務，涵蓋外科、神經技術和骨科，幫助改善患者和醫療保健結果。與全球客户一起，我們每年影響超過 1.5 億名患者。更多信息請訪問 www.stryker.com。</p>
<p>2025 年 2 月 19 日，Stryker 收購了 Inari Medical，這是一家致力於治療和改善患有靜脈及其他疾病的患者生活的醫療設備公司。</p>
<p><strong>媒體聯繫人：</strong></p>
<p>Sherri Oakson</p>
<p>高級傳播總監</p>
<p>外科和神經技術</p>
<p>[email protected]</p>
<ol>
<li>De Donato 等。INDIAN 試驗。Eur J Vasc Endovasc Surg. 2021; 61: 820-828。</li>
<li>Heller 等。使用 Rotarex 設備進行急性肢體缺血的經皮機械血栓切除。BioMed Research International. 2017。</li>
<li>Olinic 等。急性肢體缺血：診斷和管理的更新。J Clin Med. 2019。</li>
<li>旨在去除急性到慢性動脈血栓。根據與對照組的台式測試。內部數據存檔。Narula 等。JACC 2018;72:2153-63</li>
<li>根據與對照組的台式測試。內部數據存檔。注意：為了儘量減少動脈血栓遷移的風險，使用一種能夠捕捉血栓的設備可能會有幫助，但這尚未在動脈系統中證明有效。</li>
</ol>
<p>Jonathan Bowman 博士是 Inari Medical 的有償顧問。Jonathan Bowman 博士在此表達的所有觀點和意見均為他個人的觀點，並不代表 Inari Medical 的觀點。</p>
<p><strong>使用指徵：</strong> Artix 薄壁鞘管適用於：（1）非手術去除血管中的栓子和血栓。（2）將對比劑和其他液體注入、輸注和/或從血管中吸引。（3）作為血管內設備的導管。（4）用於促進將血管內導管插入並引導至選定血管。該漏斗在這些和其他血管造影程序中提供臨時血管阻塞。Artix 薄壁鞘管旨在用於外周血管。Artix MT 血栓切除設備適用於（1）非手術去除血管中的栓子和血栓；（2）將對比劑和其他液體注入、輸注和/或從血管中吸引。Artix MT 血栓切除設備旨在用於外周血管。Artix AX 吸引導管適用於（1）非手術去除血管中的栓子和血栓；（2）將對比劑和其他液體注入、輸注和/或從血管中吸引。Artix AX 吸引導管旨在用於外周血管。FlowSaver 血液回流系統與 Inari Medical 導管和鞘管一起用於自體血液輸血。</p>
<p>在使用這些產品之前，請仔細閲讀使用説明、適應症、警告、注意事項、可能的不良反應和禁忌症。</p>
<p>來源：Stryker</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzA2Jk5ld3NJdGVtSWQ9REUzNTQ2MyZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMDYxMzM2UFJfTkVXU19VU1BSX19fX19ERTM1NDYz?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzA2Jk5ld3NJdGVtSWQ9REUzNTQ2MyZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMDYxMzM2UFJfTkVXU19VU1BSX19fX19ERTM1NDYz"/></p>

NARI

<p>Inari Medical，現在是 Stryker 的一部分，推出了 Artix 血栓切除系統，旨在治療外周動脈血栓。該創新系統結合了吸引和機械血栓切除，旨在提高手術控制和靈活性。Artix 系統滿足了有效去除急性到慢性血栓的臨牀需求，可能在許多情況下替代開放手術修復。首例商業使用由 Jonathan Bowman 博士進行，突顯了其在改善動脈血栓切除患者結果方面的重要性</p>

<p>, /PRNewswire/ -- Inari Medical, now part of Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its Artix Thrombectomy System. Purpose-built for the distinct needs of the peripheral arterial system, Artix is a combined aspiration plus mechanical thrombectomy solution that delivers procedural control and versatility, and is designed to set a new standard for arterial thrombectomy.</p>
<div class="lb-trans"><p>/PRNewswire/ -- Inari Medical，現在是 Stryker（紐約證券交易所代碼：SYK）的一部分，Stryker 是全球醫療技術的領導者，宣佈推出其 Artix 血栓切除系統。Artix 專為外周動脈系統的獨特需求而設計，是一種結合了吸引和機械血栓切除的解決方案，提供了程序控制和靈活性，旨在為動脈血栓切除設定新的標準。</p>
</div><p>Continue Reading</p>
<div class="lb-trans"><p>繼續閲讀</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null" alt="" original-src="https://www.prnewswire.com/news-releases/null"/></p>
<p>Artix™ Thrombectomy System</p>
<div class="lb-trans"><p>Artix™血栓切除系統</p>
</div><p>An arterial blood clot in the leg is a life- and limb-threatening emergency requiring immediate treatment. However, existing therapies for arterial thromboembolism can lead to:</p>
<div class="lb-trans"><p>腿部的動脈血栓是一種危及生命和肢體的緊急情況，需要立即治療。然而，現有的動脈血栓栓塞治療可能導致：</p>
</div><ul>
<li>Ineffective clot retrieval leading to additional procedures (open surgery or amputation1,2)</li>
<li>Significant blood loss1</li>
<li>Adverse events such as arterial embolization and vessel trauma2,3</li>
<li>High rates of lytic use, which may result in complications1,2</li>
</ul>
<div class="lb-trans"><ul>
<li>無效的血栓取出，導致額外的手術（開放手術或截肢 1,2）</li>
<li>大量失血 1</li>
<li>不良事件，如動脈栓塞和血管損傷 2,3</li>
<li>溶栓藥物使用率高，可能導致併發症 1,2</li>
</ul>
</div><p>The Artix System builds on the success of Inari's venous thrombectomy devices and is its inaugural entry into the arterial space. Inari offers a comprehensive toolkit approach to arterial thrombectomy with an innovative, over-the-wire system that provides physicians with the flexibility to aspirate and/or mechanically extract a clot.</p>
<div class="lb-trans"><p>Artix 系統建立在 Inari 靜脈血栓切除設備成功的基礎上，是其首次進入動脈領域。Inari 提供了一種全面的工具包方法來進行動脈血栓切除，採用創新的導線系統，使醫生能夠靈活地吸引和/或機械性提取血栓。</p>
</div><p>Jonathan Bowman, MD FACS, Chief of Vascular at Norwalk Hospital in Norwalk, CT, performed the first commercial case with Artix on October 19, 2024. &#34;The Artix Thrombectomy System marks a significant advancement in peripheral arterial thromboembolism treatment,&#34; said Dr. Bowman. &#34;With Artix, I finally have a solution that effectively addresses a wide range of clots while enabling me to maintain vessel access and retain control throughout the entire case. I expect Artix will take the place of open surgical repair in many of my arterial cases.&#34;</p>
<div class="lb-trans"><p>康涅狄格州諾沃克醫院血管外科主任 Jonathan Bowman 博士於 2024 年 10 月 19 日進行了首例 Artix 商業案例。Bowman 博士表示：“Artix 血栓切除系統標誌着外周動脈血栓栓塞治療的重大進展。使用 Artix，我終於有了一個有效解決各種血栓的方案，同時能夠在整個過程中保持血管通路和控制。我預計 Artix 將在我的許多動脈病例中取代開放手術修復。”</p>
</div><p>Key distinctive features of the Artix system include:</p>
<div class="lb-trans"><p>Artix 系統的主要獨特特點包括：</p>
</div><ul>
<li><strong>Dual mechanical thrombectomy and aspiration toolkit</strong> designed to remove acute to chronic clots in a single session via a streamlined procedure4</li>
<li><strong>Aspiration-capable, 8 Fr. low profile, trackable, kink-resistant sheath in both 65cm and 90cm lengths</strong> expands treatment options by enabling more complex and distal interventions</li>
<li><strong>Innovative over-the-wire mechanical element</strong> designed to effectively collect and retrieve acute-to-chronic clot4</li>
<li><strong>Covered nitinol mesh funnel</strong> provides temporary flow restriction during the procedure to minimize the risk of arterial clot migration5</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>雙重機械血栓切除和吸引工具包</strong>，旨在通過簡化的程序在一次會話中去除急性到慢性血栓 4</li>
<li><strong>具備吸引功能的 8 Fr 低剖面、可追蹤、抗彎曲的鞘管，長度為 65cm 和 90cm</strong>，通過支持更復雜和遠端的干預擴展治療選項</li>
<li><strong>創新的導線機械元件</strong>，旨在有效收集和提取急性至慢性血栓 4</li>
<li><strong>覆蓋的鎳鈦合金網漏斗</strong>，在手術過程中提供臨時流量限制，以最小化動脈血栓遷移的風險 5</li>
</ul>
</div><p>&#34;There is a real clinical need to address chronic thrombi and decrease the risk of clot migration. Artix will raise the bar of effective arterial thrombectomy,&#34; said Tom Tu, MD, Chief Medical Officer of Inari Medical. &#34;We are excited to bring Inari's core competency in thrombectomy to the arterial space with the goal of improving outcomes.&#34;</p>
<div class="lb-trans"><p>“確實需要解決慢性血栓並降低血栓遷移的風險。Artix 將提升有效動脈血栓切除的標準，” Inari Medical 首席醫療官 Tom Tu 博士表示。“我們很高興將 Inari 在血栓切除方面的核心能力帶入動脈領域，以改善治療結果。”</p>
</div><p><strong>For more information, visit https://www.inarimedical.com/artix-system</strong></p>
<div class="lb-trans"><p><strong>欲瞭解更多信息，請訪問 https://www.inarimedical.com/artix-system</strong></p>
</div><p><strong>About Stryker</strong> Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.</p>
<div class="lb-trans"><p><strong>關於 Stryker</strong> Stryker 是全球醫療技術的領導者，與我們的客户一起，我們致力於改善醫療保健。我們提供創新的產品和服務，涵蓋外科、神經技術和骨科，幫助改善患者和醫療保健結果。與全球客户一起，我們每年影響超過 1.5 億名患者。更多信息請訪問 www.stryker.com。</p>
</div><p>On February 19, 2025, Stryker acquired Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.</p>
<div class="lb-trans"><p>2025 年 2 月 19 日，Stryker 收購了 Inari Medical，這是一家致力於治療和改善患有靜脈及其他疾病的患者生活的醫療設備公司。</p>
</div><p><strong>Media contact:</strong></p>
<div class="lb-trans"><p><strong>媒體聯繫人：</strong></p>
</div><p>Sherri Oakson</p>
<div class="lb-trans"><p>Sherri Oakson</p>
</div><p>Senior Director, Communications</p>
<div class="lb-trans"><p>高級傳播總監</p>
</div><p>MedSurg and Neurotechnology</p>
<div class="lb-trans"><p>外科和神經技術</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><ol>
<li>De Donato et al. The INDIAN Trial. Eur J Vasc Endovasc Surg. 2021; 61: 820-828.</li>
<li>Heller et al. Percutaneous Mechanical Thrombectomy Using Rotarex Device in Acute Limb Ischemia in Infrainguinal Occlusions. BioMed Research International. 2017.</li>
<li>Olinic et al. Acute Limb Ischemia: An Update on Diagnosis and Management. J Clin Med. 2019.</li>
<li>Designed to remove acute to chronic arterial clots. According to benchtop testing compared to control. Internal data on file. Narula et al. JACC 2018;72:2153-63</li>
<li>According to benchtop testing compared to control. Internal data on file. NOTE: To attempt to minimize risk of arterial embolization of blood clots, use of a device that entraps clots may potentially be helpful, but this has not yet been demonstrated to be effective in the arterial system.</li>
</ol>
<div class="lb-trans"><ol>
<li>De Donato 等。INDIAN 試驗。Eur J Vasc Endovasc Surg. 2021; 61: 820-828。</li>
<li>Heller 等。使用 Rotarex 設備進行急性肢體缺血的經皮機械血栓切除。BioMed Research International. 2017。</li>
<li>Olinic 等。急性肢體缺血：診斷和管理的更新。J Clin Med. 2019。</li>
<li>旨在去除急性到慢性動脈血栓。根據與對照組的台式測試。內部數據存檔。Narula 等。JACC 2018;72:2153-63</li>
<li>根據與對照組的台式測試。內部數據存檔。注意：為了儘量減少動脈血栓遷移的風險，使用一種能夠捕捉血栓的設備可能會有幫助，但這尚未在動脈系統中證明有效。</li>
</ol>
</div><p>Dr. Jonathan Bowman is a paid consultant of Inari Medical. All views and opinions expressed here by Dr. Jonathan Bowman are his own and do not represent those of Inari Medical.</p>
<div class="lb-trans"><p>Jonathan Bowman 博士是 Inari Medical 的有償顧問。Jonathan Bowman 博士在此表達的所有觀點和意見均為他個人的觀點，並不代表 Inari Medical 的觀點。</p>
</div><p><strong>Indications for Use:</strong> The Artix thin-walled sheath is indicated for: (1) The non-surgical removal of emboli and thrombi from blood vessels. (2) Injection, infusion and/or aspiration of contrast media and other fluids into or from a blood vessel. (3) Use as a conduit for endovascular devices. (4) Use in facilitating the insertion and guidance of an intravascular catheter into a selected blood vessel. The funnel provides temporary vascular occlusion during these and other angiographic procedures. The Artix thin-walled sheath is intended for use in the peripheral vasculature. The Artix MT thrombectomy device is indicated for (1) the non-surgical removal of emboli and thrombi from a blood vessel; and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Artix MT thrombectomy device is intended for use in the peripheral vasculature. The Artix AX aspiration catheter is indicated for (1) the non-surgical removal of emboli and thrombi from blood vessels; and (2) injection, infusion, and/or aspiration of contrast media and other fluids into or from a blood vessel. The Artix AX aspiration catheter is intended for use in the peripheral vasculature. The FlowSaver blood return system is used with Inari Medical catheters and sheaths for autologous blood transfusion.</p>
<div class="lb-trans"><p><strong>使用指徵：</strong> Artix 薄壁鞘管適用於：（1）非手術去除血管中的栓子和血栓。（2）將對比劑和其他液體注入、輸注和/或從血管中吸引。（3）作為血管內設備的導管。（4）用於促進將血管內導管插入並引導至選定血管。該漏斗在這些和其他血管造影程序中提供臨時血管阻塞。Artix 薄壁鞘管旨在用於外周血管。Artix MT 血栓切除設備適用於（1）非手術去除血管中的栓子和血栓；（2）將對比劑和其他液體注入、輸注和/或從血管中吸引。Artix MT 血栓切除設備旨在用於外周血管。Artix AX 吸引導管適用於（1）非手術去除血管中的栓子和血栓；（2）將對比劑和其他液體注入、輸注和/或從血管中吸引。Artix AX 吸引導管旨在用於外周血管。FlowSaver 血液回流系統與 Inari Medical 導管和鞘管一起用於自體血液輸血。</p>
</div><p>Review complete Instructions for Use, Indications for Use, Warnings, Precautions, Possible Adverse Effects and Contraindications prior to use of these products.</p>
<div class="lb-trans"><p>在使用這些產品之前，請仔細閲讀使用説明、適應症、警告、注意事項、可能的不良反應和禁忌症。</p>
</div><p>SOURCE Stryker</p>
<div class="lb-trans"><p>來源：Stryker</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwMzA2Jk5ld3NJdGVtSWQ9REUzNTQ2MyZUcmFuc21pc3Npb25fSWQ9MjAyNTAzMDYxMzM2UFJfTkVXU19VU1BSX19fX19ERTM1NDYz" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=DE35463&amp;Transmission_Id=202503061336PR_NEWS_USPR_____DE35463&amp;DateId=20250306"/></p>

13:36 ET
			
			
				Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases

Inari Medical，現在是 Stryker 的一部分，推出了 Artix™ Thrombectomy System，旨在解決廣泛的動脈血栓病例